Store
The Market for RNA Sequencing, 3rd Edition
Publication Date: September 28, 2023
Tags: Clinical Diagnostics, Genetic Diseases, Hematology, Infectious Disease Testing Instruments, Next-Generation Sequencing (NGS), Next-Generation Sequencing (NGS) Systems, Oncology and Cancer, Sequencing, Sequencing Technologies
Pages: 60
SKU: 23-041
Kalorama Information presents the latest insights and comprehensive analysis in its new report, The Market for RNA Sequencing, 3rd Edition. This essential market research report delves into the rapidly evolving RNA sequencing sector, highlighting the remarkable advancements and applications that promise to revolutionize healthcare.
Overview:
In the past decade, the sequencing market has witnessed explosive growth, marked by numerous product introductions, innovative applications, and a surge of end-user laboratories eager to explore new areas. RNA sequencing (RNA-seq) has emerged as a powerful tool, outpacing traditional methods like microarrays and quantitative reverse transcription-PCR (q-RT-PCR). RNA-seq offers significant advantages, including:
- Improved sensitivity and dynamic range
- Ability to study species without reference
- Measurement of focal changes such as single nucleotide variants, insertions, and deletions
- Detection of different transcript isoforms, splice variants, and chimeric gene fusions
Key Insights and Market Segments:
This report provides a comprehensive analysis of the RNA sequencing market, covering:
- RNA Sequencing Market (2022 and 2027): Market size and growth forecasts.
- RNA Sequencing Consumables Market (2022 and 2027): Insights into consumables used in RNA-seq.
- RNA Sequencing Equipment-Related Services Market (2022 and 2027): Analysis of services supporting RNA sequencing hardware.
- RNA Sequencing Software Market (2022 and 2027): Overview of software products aiding RNA-seq.
- RNA Sequencing Vendor Share: Detailed vendor share information.
- Products on the Market: Comprehensive list of RNA sequencing products.
- Software Products: Key software tools for RNA-seq.
- Innovations: Latest advancements and innovations in RNA sequencing.
- Clinical Sequencing and Products on the Market: Focus on clinical applications and products.
Competitive Landscape and Market Dynamics:
The report discusses trends, challenges, strategies, companies, and products shaping the RNA sequencing market. It provides detailed estimates of market share and revenue growth, competitive situations, and key deals in the industry. Each chapter offers insights into the market dynamics, enabling businesses to make informed decisions and stay ahead of the competition.
Table: RNA Sequencing Market Revenue Share, by Region (millions of dollars and percent)
| Region | Revenues ($M) | Share |
| North America | $XX Million | XX% |
| Europe | $XX Million | XX% |
| APAC | $XX Million | XX% |
| ROW | $XX Million | XX% |
| Total | $XX Million | XX% |
Source: Kalorama Information
For further details and to purchase directly, please contact us.
Table of Contents
Chapter 1: Executive Summary
- Table 1-1: RNA Sequencing Revenues by Product Segment (Consumables, Systems/Hardware, Service, and Software), 2022 (in millions of $)
- Figure 1-1: RNA Sequencing Revenues by Product Segment (Consumables, Systems/Hardware, Service, and Software), 2022 (percent)
Scope and Methodology
Report Structure
Chapter 2: Market Trends
Introduction
Trends
Clinical Diagnostics, Clinical Research Applications
Cancer – leukemia/ hematological diseases; solid tumors
Infectious diseases
Rare inherited/ genetic diseases
- Table 2-1: Selected RNA-Seq Diagnostic/ Clinical Products and Technologies
COVID-19
Illumina’s Diverse Range of Products
Other Companies’ NGS Products and Technologies
CDC’s SPHERES Consortium
Ongoing Introductions of New Products
- Table 2-2: RNA-Sequencing Product Introductions, October 2018- July 2023
Single-cell RNA Sequencing
Selected Products/ Technologies
- Table 2-3: Selected RNA-Seq Products and Technologies
Software/Bioinformatics
- Table 2-4: Selected RNA-Seq Software and Related IT Tools
Partnerships, Acquisitions, Deals in Many Areas
- Table 2-5: RNA-Seq Collaborations, Acquisitions and Other Deals, October 2014-August 2023
CHAPTER 3: MARKET ANALYSIS
Market Analysis
- Table 3-1: RNA Sequencing Revenues, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2022-2027 (in millions of dollars)
- Figure 3-1: RNA Sequencing Revenues, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2022-2027 (in millions of dollars)
- Table 3-2: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2022-2027 (percent)
- Figure 3-2: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2022 (percent)
- Figure 3-3: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2027 (percent)
Market Shares
- Table 3-3: RNA Sequencing Market Revenue Share, by Leading Companies (Illumina, Thermo, and Other), 2022 (millions of dollars and percent)
- Figure 3-4: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2022 (percent)
- Table 3-4: RNA Sequencing Market Revenue Share, by Region (North America, Europe, APAC, and Rest of World), 2021 (millions of dollars and percent)
- Figure 3-5: RNA Sequencing Market Revenue Share, by Region (North America, Europe, APAC, and Rest of World), 2021 (percent)
CHAPTER 4: COMPANY PROFILES
Company Profiles
10X Genomics
Agilent Technologies
Illumina
New England Biolabs
Oxford Nanopore Technologies
Pacific Biosciences (PacBio)
Standard BioTools
Takara Bio Inc.
Tecan
Thermo Fisher Scientific
Related products
Hematology and Coagulation Markets, 2023
April 5, 2023
Discover the lucrative $10 billion-dollar market for hematology and coagulation in vitro diagnostic (IVD) testing with Kalorama’s comprehensive report, Hematology and Coagulation Markets, 2023. This analysis delves into the dynamic growth factors driving this market, including new technologies, the aging population, and the increasing demand for decentralized testing.
Key Insights Provided:
- Market sizing…
Price range: $3,000.00 through $4,500.00
Clinical Laboratory Services Market, 8th Edition
May 18, 2023
Laboratories are the workhorse of diagnostic services for the IVD market. These laboratories play a vital role in providing analysis of a wide range of disorders and diseases including pathology, immunology, cholesterol testing, allergy testing, urinalysis, genetic testing and many more. Kalorama Information’s Clinical Laboratory Services Market, 8th Edition is your comprehensive resource for insights…
Price range: $4,000.00 through $6,000.00
The Market and Future Potential for Molecular Point-of-Care (mPOC), 11th Edition
March 7, 2024
Explore the cutting-edge world of molecular point-of-care (mPOC) diagnostic solutions with our latest report, offering a detailed analysis of the market and future growth potential from 2023-2028. mPOC technology revolutionizes diagnostic capabilities, providing enhanced sensitivity and specificity compared to traditional near-patient tests. These solutions are instrumental in critical care units, physician offices, outpatient clinics,…
Price range: $5,000.00 through $7,875.00
